ErbB2/Her2 anticorps

N° du produit ABIN3026574

L’anticorps anti-ErbB2/Her2 Monoclonal Souris est utilisé pour la détection de ErbB2/Her2 dans des échantillons de Humain. Il a été validé pour IF, ELISA et FACS.

Aperçu rapide pour ErbB2/Her2 anticorps (ABIN3026574)

Antigène: ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ErbB2/Her2 est non-conjugé

Application: Immunofluorescence (IF), ELISA, Flow Cytometry (FACS)

Classe de qualité: Carrier-free

Clone: HRB2-258

Détail du produit anti-ErbB2/Her2 anticorps

Fonction: ErbB2 Antibody / HER2 (azide and preservative free)

Purification: Protein G purified

Immunogène: Recombinant human protein was used as the immunogen for this ErbB2 antibody.(1)

Isotype: IgG2a, kappa

Information d'application

Indications d'application: Variations in protocols, secondaries and substrates may require the antibody to be titered for optimal performance.

1. This ErbB2 antibody binds to the extracellular/cell surface region of the protein.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the ErbB2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur ErbB2/Her2

Antigène: ErbB2/Her2 (Receptor tyrosine-protein kinase erbB-2 (ErbB2/Her2))

Autre désignation: ErbB2

Sujet: This antibody recognizes a protein of 185 kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. ErbB2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary.

Pathways: Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Skeletal Muscle Fiber Development